Viral hepatitis is a leading public health threat in the United States. Three related viruses—hepatitis A (HAV), B (HBV), and C (HCV)—cause liver inflammation and contribute to liver transplants and cancer, ultimately killing more Americans than any other infectious disease. We have the tools to stop outbreaks of HAV and eliminate HBV and HCV, but social and structural barriers, stigma and discrimination, and insufficient funding for the public health response limit access to hepatitis services. NACCHO works with local health departments to address these challenges and advance the prevention and elimination of viral hepatitis.

NACCHO’s Model Practices Program nationally honors and recognizes outstanding local public health practice and shares the outstanding practices through the Model Practices Database. By submitting a practice, LHDs contribute to the overall improvement of public health through effective evidence-based practice methods.

Model Practices are awarded to local health departments across the country for implementing programs that demonstrate exemplary and replicable outcomes in response to an identified public health need. Promising Practices are exciting approaches and strategies to local public health issues that are on track to becoming Model Practices. Each awarded practice was reviewed by a committee of peers, made up of other local health department professionals, and selected from a competitive collection of applications.

View the drop-downs below to access select STI-related Model Practice and Promising Practice award winners from the last two years. To view all Model Practice awardees from previous years, visit our searchable database.

For questions about NACCHO's work regarding viral hepatitis prevention, detection, and response, contact our hepatitis specialists below.